Markets › Stocks › VINRKLB
VI

Rekvina Laboratories Ltd

NSE: VINRKLBBSE: 526075Healthcare
Download Research Report7-page PDF
₹41.43
▲ +0.00%
NSE · auto-updates while market open
Mkt Cap
₹12 Cr
P / E
-
P / B
-
ROE
-
52W High
₹46.65
52W Low
₹4.50
Key Metrics
Market Cap
₹12 Cr
P / E
-
P / B
-
EV / EBITDA
-
ROCE
-
ROE
-
Debt / Equity
-
Book Value
₹-4.07
EPS
-
Div Yield
0.0%
Face Value
-
Promoter Holding
41.3%
Revenue · ₹ Cr
0
FY22
0
FY23
0
FY24
0
FY25
1
FY26
Net Profit · ₹ Cr
0
0
0
0
0
FY22FY23FY24FY25FY26
EPS · ₹ per share
₹-0.1
₹-0.0
FY22FY23
Q1 2026 snapshot
Sales
₹1 Cr
Operating profit
-
OPM
-
Net profit
₹-0 Cr
EPS
-
Scorecard · 7 axes
Quality
-
Valuation
-
Growth
-
Profitability
-
Performance
Strong
+820.7%
Entry Point
Avg
89%
Red Flags
Strong
0 flags
Shareholding Pattern
41.3%Promoter
Promoter41.3%
Public58.7%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue0000.20.350.72
Net Profit-0.024-0.043-0.035-0.035-0.124-0.061
NPM %----17.4%-35.4%-8.4%
AlertPre-trade